News |  Contact |  Sitemap |  Disclaimer | 
About us  |   Services  |   Territories  |   Partners  |  
NEWS
Shield Therapeutics and Ewopharma sign Feraccru licence agreement for Switzerland
06.07.2017
Shield Therapeutics plc (LSE:STX), a speciality pharmaceutical company focused on secondary care, and Ewopharma AG, a pharmaceutical ...


Ewopharma strengthens its oncology business
22.06.2017
Eisai Co. Ltd and Ewopharma AG have signed an agreement with which Ewopharma acquires the rights to commercialise several of Eisai's ...


Welcome to Ewopharma.
Your entry to the pharmaceutical markets of Central Eastern Europe.